BioSewoom

BioSewoom is a South Korea-based molecular diagnostics company focused on in vitro diagnostic reagents and assay kits for infectious diseases, oncology, pharmacogenetics, HLA typing, and related molecular testing applications. The company markets a broad portfolio under its Real-Q brand, including assays for SARS-CoV-2, respiratory pathogens, CYP2C19 genotyping, HLA-B27 and HLA-B51 typing, ApoE genotyping, and multiple oncology-associated mutations and fusion genes. BioSewoom appears to operate as a commercial-stage diagnostics manufacturer rather than a therapeutics developer, with products positioned for hospital and laboratory use. Its capabilities center on PCR and other molecular genetic testing technologies, and the company highlights domestic regulatory approvals and certifications in Korea. BioSewoom also indicates development of an all-in-one point-of-care platform in its recent corporate history.